| 军队新药研发项目的风险评估体系研究 |
| 投稿时间：2014-12-17 修订日期：2015-02-03 点此下载全文 |
| 引用本文：陈静,陆峰,舒丽芯.军队新药研发项目的风险评估体系研究[J].药学实践杂志,2017,35(1):54~59 |
| 摘要点击次数: 1246 |
| 全文下载次数: 1429 |
|
|
| 中文摘要:目的 风险管理是保证新药研发项目顺利进行的强有力措施。因此，建立适合新药研发项目的风险评估指标体系对提高医药项目成功率至关重要。方法 对近5年来“军队科技重大专项”支持的20多个新药研发项目进行分析，归纳、整理和总结出新药研发项目的风险因素，通过德尔菲法和专家访谈法明确风险评价指标体系，并采用基于层次分析法的模糊综合评价法，对体系的指标进行定量研究。结果 按照不同阶段的新药研发项目，分别建立了药物候选阶段、药物临床前阶段和药物临床阶段的风险评估指标体系和权重。结论 本指标体系较为客观准确，有助于新药研发项目中的风险控制。 |
| 中文关键词:药品研发项目 风险管理 评价指标 模糊综合评价法 |
| |
| Risk evaluation system of new drug research and development projects in the military |
|
|
| Abstract:Objective Risk management is one of the strong measurements to ensure the conduction of new drug research and development (R&D) projects. Therefore, establishing a set of evaluation index system in the new drug R&D projects is of great significance to increase the project success rate.Methods By analyzing more than 20 new drug R&D projects of "the military science and technology major projects" in five years, the risk factors were induced, sorted and summed up, and a set of evaluation indicator was built up through Delphi method and experts interview. The quantitative study was completed through fuzzy comprehensive evaluation method.Results According to the different stages of new drug R&D projects, the risk assessment indictors and their weight were established.Conclusion These indicators are more objective and accurate which contribute to the risk control in the process of new drug R&D projects. |
| keywords:new drug research and development project risk management evaluation indicator fuzzy comprehensive evaluation method |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
